Cancer
At the Kolling Institute, our cancer research aims to identify and overcome the factors that drive cancer development so that we can improve patient outcomes. We have a number of cancer research teams with different expertise, specialising in chemotherapy resistance, immunotherapies, genetics, epigenetics, diagnostic services and clinical trials. Importantly, these teams have access to an active tissue bank and the latest equipment.
Our cancer research rapidly implements laboratory findings into clinical practice and is supported by the Cancer Institute Translational Centre, Sydney Vital. By bringing together research scientists, clinicians and allied health professionals, we are able to combine innovative and cutting edge research with personalised treatment strategies for cancer patients.
Find out more about:
Bill Walsh Translational Cancer Research Laboratory
Bowel Cancer and Biomarker Research Lab
Breast Cancer Research
Cancer Genetics Laboratory
Kolling Institute Tumour Bank
Events, News and Seminars
Valuable new funds support game-changing cancer research
Posted on: 26 July, 2024
Our ground-breaking leukaemia research at the Kolling Institute has received an important boost with..... Read more
Category: Funding support, Research Excellence
Kolling researchers make promising breakthrough with leukaemia study
Posted on: 01 July, 2024
While there has been a great deal of encouraging progress with many cancer treatments over the last ..... Read more
Category: Funding support, Research Excellence
Running for game-changing research
Posted on: 29 May, 2024
Less than two years after a breast cancer diagnosis, Professor Gemma Figtree has completed the prest..... Read more
Category: Cardiovascular and Renal Research, Funding support, Research Excellence